Company

Robocath SAS

Robocath SAS develops robotic systems for percutaneous coronary interventions, led by its R-One product.

About

Founded in 2009 and based in Roubaix, France, Robocath develops and sells robotic systems for interventional vascular medicine. Its R-One system assists coronary procedures and targets cardiologists in Europe, Africa and China. Philippe Bencteux is the founder. The company raised EUR 17 million in venture debt in January 2022 and reports a total of USD 9.00 mn across 9 deals. It reported 2022 revenue of USD 766,131.80 and EBITDA of USD -7,906,115.70.

6Funding rounds

6Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in